Interleukin 10 induced augmentation of delayed-type hypersensitivity (DTH) enhances Mycobacterium bovis bacillus Calmette-Guérin (BCG) mediated antitumour activity. (Q54792101)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Interleukin 10 induced augmentation of delayed-type hypersensitivity (DTH) enhances Mycobacterium bovis bacillus Calmette-Guérin (BCG) mediated antitumour activity.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12562379%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Interleukin 10 induced augmentation of delayed-type hypersensitivity (DTH) enhances Mycobacterium bovis bacillus Calmette-Guérin (BCG) mediated antitumour activity (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12562379%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Mycobacterium bovis

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12562379%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12562379%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

author name string

R Nadler

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12562379%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

W Zhao

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12562379%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

J K Ritchey

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12562379%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

J C Austin

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12562379%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

M B Cohen

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12562379%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

T L Ratliff

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12562379%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12562379%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Clinical and Experimental Immunology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12562379%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

131

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12562379%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12562379%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

206-216

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12562379%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Urinary cytokines during intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: processing, stability and prognostic value

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02071.X

21 January 2018

New use of BCG for recombinant vaccines

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02071.X

21 January 2018

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

2 references

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02071.X

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808633

25 August 2018

Improved patient outcomes with BCG immunotherapy vs. chemotherapy - Swedish and worldwide experience

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02071.X

21 January 2018

Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02071.X

21 January 2018

Intravesical versus intravesical plus intradermal bacillus Calmette-Guerin: a prospective randomized study in patients with recurrent superficial bladder tumors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02071.X

21 January 2018

Differential effects of cytolytic T cell subsets on intracellular infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02071.X

21 January 2018

Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02071.X

21 January 2018

Estrogen treatment down-regulates TNF-alpha production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02071.X

21 January 2018

Humoral response against heat shock proteins and other mycobacterial antigens after intravesical treatment with bacille Calmette-Guérin (BCG) in patients with superficial bladder cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808633

25 August 2018

Mechanisms of action of bacillus Calmette-Guérin in the treatment of superficial bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808633

25 August 2018

Dissecting the immunobiological effects of Bacillus Calmette-Guérin (BCG) in vitro: evidence of a distinct BCG-activated killer (BAK) cell phenomenon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808633

25 August 2018

Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808633

25 August 2018

Regulation of contact hypersensitivity by interleukin 10.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808633

25 August 2018

Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808633

25 August 2018

T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guérin-infected resistant and susceptible mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808633

25 August 2018

Ultrastructural studies of histiocyte-tumor cell interactions during tumor regression after intralesional injection of Mycobacterium bovis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808633

25 August 2018

Immunotherapy of cancer: regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of living Mycobacterium bovis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808633

25 August 2018

Analysis of mucosal bladder leucocyte subpopulations in patients treated with intravesical Bacillus Calmette-Guerin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808633

25 August 2018

Expression of the nerve growth factor-regulated NGFI-A and NGFI-B genes in the developing rat.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808633

25 August 2018

Modulation of fibronectin-mediated Bacillus Calmette-Guérin attachment to murine bladder mucosa by drugs influencing the coagulation pathways

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808633

25 August 2018

Characterization of fibronectin attachment by a human transitional cell carcinoma line, T24.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808633

25 August 2018

Bacillus Calmette-Guérin (BCG): mechanism of action in superficial bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808633

25 August 2018

A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808633

25 August 2018

Murine bladder carcinoma cells present antigen to BCG-specific CD4+ T-cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808633

25 August 2018

Long-term results of intravesical therapy for superficial bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808633

25 August 2018

Role of the immune response in BCG for bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808633

25 August 2018

Immune response toMycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808633

30 November 2018

Characterization of the fibronectin binding motif for a unique mycobacterial fibronectin attachment protein, FAP

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02071.X

21 January 2018

Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02071.X

21 January 2018

Bacillus Calmette-Guérin plus interleukin-2 and/or granulocyte/macrophage-colony-stimulating factor enhances immunocompetent cell production of interferon-gamma, which inhibits B16F10 melanoma cell growth in vitro

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02071.X

21 January 2018

Stimulation of CD40 in human bladder carcinoma cells inhibits anti-Fas/APO-1 (CD95)-induced apoptosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02071.X

21 January 2018

Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall

1 reference

https://pubmed.ncbi.nlm.nih.gov/12562379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Technical factors affecting the reproducibility of intravesical mouse bladder tumor implantation during therapy with Bacillus Calmette-Guérin

1 reference

https://pubmed.ncbi.nlm.nih.gov/12562379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of bacillus-Calmette-Guérin-activated killer cells from human peripheral blood mononuclear cells against human bladder carcinoma cell lines in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/12562379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-cell subsets required for intravesical BCG immunotherapy for bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12562379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after bacillus Calmette-Guérin (BCG) immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12562379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune responses in mice after gastric and subcutaneous immunization with BCG

1 reference

https://pubmed.ncbi.nlm.nih.gov/12562379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimizing syngeneic orthotopic murine bladder cancer (MB49)

1 reference

https://pubmed.ncbi.nlm.nih.gov/12562379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/12562379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of purified protein derivative skin test and granuloma formation in patients treated with intravesical bacillus Calmette-Guerin

1 reference

https://pubmed.ncbi.nlm.nih.gov/12562379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of murine bladder tumor growth by bacille Calmette-Guerin: lack of a role of natural killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/12562379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of interleukin 2 in the urine of patients with superficial bladder tumors after treatment with intravesical BCG

1 reference

https://pubmed.ncbi.nlm.nih.gov/12562379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Requirement of a thymus dependent immune response for BCG-mediated antitumor activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/12562379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ureteral carcinoma in situ after successful intravesical therapy for superficial bladder tumors: incidence, possible pathogenesis and management

1 reference

https://pubmed.ncbi.nlm.nih.gov/12562379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of 6 Weekly Intravesical Bacillus Calmette-Guerin Instillations on the Treatment of Superficial Bladder Tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/12562379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12562379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro and in vivo anti-tumor activity of recombinant mouse tumor necrosis factor (TNF) in a mouse bladder tumor (MBT-2)

1 reference

https://pubmed.ncbi.nlm.nih.gov/12562379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevations of cytokines interleukin-1, interleukin-2 and tumor necrosis factor in the urine of patients after intravesical bacillus Calmette-Guerin immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12562379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12562379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term complete remission in bladder carcinoma in situ with intravesical TICE bacillus Calmette Guerin. Overview analysis of six phase II clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/12562379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of a bacillus Calmette-Guérin fibronectin attachment protein in BCG-induced antitumor activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/12562379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1046/J.1365-2249.2003.02071.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12562379%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12562379%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54792101&oldid=1961042572"